コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 phs that were read by an ophthalmologist who was masked to treatment assignment.
2 No one was masked to treatment assignment.
3 The study was open label and no-one was masked to treatment assignment.
4 No one was masked to treatment assignment.
5 nts and clinical, data, and laboratory staff were masked to treatment assignment.
6 ff, investigators, and all sponsor personnel were masked to treatment assignment.
7 staff with the exception of site pharmacists were masked to treatment assignment.
8 Providers and women were masked to treatment assignment.
9 er patients nor investigators or their teams were masked to treatment assignment.
10 considered by the trial management team, who were masked to treatment assignment.
11 with the exception of the neurosurgical team were masked to treatment assignment.
12 ly researchers who did the 6-month follow-up were masked to treatment assignment.
13 Participants and investigators were masked to treatment assignment.
14 Patients and investigators were masked to treatment assignment.
15 y investigators, and study sponsor personnel were masked to treatment assignment.
16 The patients, investigators, and site staff were masked to treatment assignment.
17 essing outcomes, and sponsor study personnel were masked to treatment assignment.
18 Investigators, patients, and the funder were masked to treatment assignment.
19 Investigators and patients were masked to treatment assignment.
20 Patients and study personnel were masked to treatment assignment.
21 dividuals involved in analysis of trial data were masked to treatment assignment.
22 patients, physicians, and outcome assessors were masked to treatment assignment.
23 ministering treatment and assessing outcomes were masked to treatment assignment.
24 Neither patients nor investigators were masked to treatment assignment.
25 All investigators assessing outcomes were masked to treatment assignment.
26 All study personnel and participants were masked to treatment assignment.
27 atients, their families, and all trial staff were masked to treatment assignment.
28 Patients were masked to treatment assignment.
29 ommittee members, and the study statistician were masked to treatment assignment.
30 Patients and investigators were masked to treatment assignment.
31 atients, investigators, and study site staff were masked to treatment assignment.
32 tients, investigators, and the study sponsor were masked to treatment assignment.
33 l, except for pharmacists and statisticians, were masked to treatment assignment.
34 Patients, investigators, and clinicians were masked to treatment assignment.
35 tients, investigators, staff, and the funder were masked to treatment assignment.
36 Patients and study investigators were masked to treatment assignment.
37 medical staff, investigators, and the funder were masked to treatment assignment.
38 en-label, but those doing tumour assessments were masked to treatment assignment.
39 ndividuals who handled and analysed the data were masked to treatment assignment.
40 articipants, caregivers, and study personnel were masked to treatment assignment.
41 investigators, staff, and outcome assessors were masked to treatment assignment.
42 Participants and study staff were masked to treatment assignment.
43 articipants, clinicians, and trial personnel were masked to treatment assignment.
44 ticipants' families, and data analysis teams were masked to treatment assignment.
45 hedule, and all patients and study personnel were masked to treatment assignment.
46 All participants were masked to treatment assignment.
47 The research team and parents of the infants were masked to treatment assignment.
48 rsonnel, including those assessing outcomes, were masked to treatment assignment.
49 Patients and investigators were masked to treatment assignment.
50 Participants and care providers were masked to treatment assignment.
51 Study personnel and patients were masked to treatment assignment.
52 Both patients and study personnel were masked to treatment assignment.
53 Patients and investigators were masked to treatment assignment.
54 Study participants were masked to treatment assignment.
55 all such events were classified by staff who were masked to treatment assignment.
56 Only the raters were masked to treatment assignment.
57 staff involved in review or analysis of data were masked to treatment assignment.
58 n, clinical research staff, and participants were masked to treatment assignment.
59 udy sponsor, participants, and investigators were masked to treatment assignment.
60 All participants and study personnel were masked to treatment assignment.
61 tients, investigators, and the study sponsor were masked to treatment assignment.
62 udy management, site personnel, and patients were masked to treatment assignment.
63 Participants and investigators were masked to treatment assignment.
64 ing the interventions, and outcome assessors were masked to treatment assignment.
65 Patients, study personnel, and the sponsor were masked to treatment assignment.
66 Patients and staff at each site were masked to treatment assignment.
67 pants, the bronchoscopist, and immunologists were masked to treatment assignment.
68 Participants, family members, and site staff were masked to treatment assignment.
69 All participants and site personnel were masked to treatment assignment.
70 All patients and study personnel were masked to treatment assignment.
71 tients, data analysts, and the trial sponsor were masked to treatment assignment.
72 Investigators, site staff, and patients were masked to treatment assignment.
73 Participants and carers were masked to treatment assignment.
74 therwise stated, participants and clinicians were masked to treatment assignment.
75 s (except for a cardiac safety review panel) were masked to treatment assignment.
76 udy sponsor, participants, and investigators were masked to treatment assignment.
77 ch organisation, investigators, and patients were masked to treatment assignment.
78 the study monitor, and the Vertex study team were masked to treatment assignment.
79 those undertaking study-related assessments were masked to treatment assignment.
80 Patients, clinicians, and data analysts were masked to treatment assignment.
81 Patients and investigators were masked to treatment assignment.
82 Investigators and participants were masked to treatment assignment.
83 vestigators, patients, and the trial sponsor were masked to treatment assignment.
84 Patients, study staff, and investigators were masked to treatment assignment.
85 Patients and investigators were masked to treatment assignments.
86 Patients, investigators, and study staff were masked to treatment assignments.
87 tients, investigators, and the trial sponsor were masked to treatment assignments.
88 tigators, and personnel conducting the study were masked to treatment assignments.
89 e system, and patients and all investigators were masked to treatment assignments.
90 pants, investigators, and research personnel were masked to treatment assignments.
91 System and both patients and study personnel were masked to treatment assignments.
92 essment of clinical safety, and participants were masked to treatment assignments.
93 System and both patients and study personnel were masked to treatment assignments.
94 ll participants, investigators, and sponsors were masked to treatment assignments.
95 ent was concealed at randomisation (everyone was masked to treatment assignment, achieved by the use
97 study staff, including the central readers, were masked to treatment assignment apart from the pharm
105 ed to treatment assignment; the statistician was masked to treatment assignment for the analysis of p
108 investigators (including local radiologists) were masked to treatment assignment from randomisation u
110 clinical trial site staff, and pathologists were masked to treatment assignment throughout the study
111 rtners (generally carers), and all assessors were masked to treatment assignment throughout the study
112 tment assignment; however, the study sponsor was masked to treatment assignment until database lock.
115 sonnel, investigators, and Amgen study staff were masked to treatment assignments within dosing frequ
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。